08/2026 – AstronDX Technologies has received regulatory approval for its new LyteStar™ TB-MDR PCR Kit, expanding the company’s molecular diagnostics portfolio for tuberculosis and antimicrobial resistance.
08/2026 – AstronDX Technologies has received regulatory approval for its new LyteStar™ TB-MDR PCR Kit, expanding the company’s molecular diagnostics portfolio for tuberculosis and antimicrobial resistance.
05/2026 – AstronDX and ADT Molecular are pleased to announce the award of two public health laboratory tenders in Malaysia for the supply of AstronDX proprietary LyteStar™ MDx kits.
04/2026 – ADT Molecular has been awarded a tender by the Malaysian Public Health Laboratories, Kota Bharu branch (Makmal Kesihatan Awam Kota Bharu), for the supply of AstronDX’s LyteStar™ Influenza Typing RT-PCR kits. The kits will support surveillance screening and epidemiological studies across the northern region of Peninsular Malaysia.
04/2026 – AstronDX Technologies is happy to announce the regulatory approval of the LyteStar™ Arbovirus ZCD kit for detection and differentiation of Dengue, Chikungunya and Zika virus in Thailand.
2/2026 – AstronDX Technologies is pleased to announce that the Thai Food and Drug Administration (FDA) has granted regulatory approval for the LyteStar™ TB/NTM and LyteStar™ Enterovirus HFMD kits.
10/2025 – ADT Molecular has been awarded a tender by Hospital Sungai Buloh to supply our LyteStar™ MERS-CoV RT-PCR kit for the detection of Middle East Respiratory Syndrome (MERS) Coronavirus. The kit will be used to screen returning pilgrims from the Arabian peninsula with an indication of potential exposure.
